Ulrich Dauer
Director/Board Member at Atriva Therapeutics GmbH
Net worth: 26 719 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Clemens M. Doppler | M | 64 | 19 years | |
| Piet Wigerinck | M | 58 |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | - |
| Michael Schaeffer | M | 56 | 6 years | |
| Manfred Rüdiger | M | 59 | 19 years | |
| Helmut Jeggle | M | 53 | 16 years | |
| Christian Pangratz | M | - |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | 1 years |
| Samir Shah | M | 63 | 2 years | |
| Irina Antonijevic | M | 59 | 12 years | |
| Michael Grissinger | M | 70 |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | 4 years |
| Christian Wallasch | M | - |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | - |
| Claudia Riedl | M | 54 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jörg Neermann | M | 57 | 12 years | |
| Dinnies Johannes von der Osten | M | 62 | 16 years | |
| Daniel Vitt | M | 55 | 19 years | |
| Enno Spillner | M | 55 | 11 years | |
| Roland Baumgartner | M | - | - | |
| Inge Lues | M | - | 10 years | |
| Florian Schmid | M | 50 | 3 years | |
| Günter Frankenne | M | - | 4 years | |
| Brian D. Morgan | M | - | - | |
| Bernd Hentsch | M | 64 | - | |
| Klaus Kühn | M | 72 | 2 years | |
| Stefan Busemann | M | - | - | |
| Manfred Gröppel | M | 55 | - | |
| Thomas Werner | M | 68 | 5 years | |
| Klaus-Peter Gulden | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 26 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ulrich Dauer
- Personal Network
